Business Context and Reporting Period
Lifeward Ltd. (LFWD), incorporated in Israel with principal offices in Marlborough, MA, filed this Form 8-K on August 5, 2025. The filing addresses a regulatory notice received from The Nasdaq Stock Market LLC regarding the Company's compliance with listing standards.
Key Financial Metrics
This filing is a Current Report (Form 8-K) and does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial metrics.
Material Changes
The material event reported is a deficiency notice from Nasdaq. For the 30 consecutive business days preceding August 5, 2025, the closing bid price of Lifeward's ordinary shares remained below the minimum $1.00 per share required under Nasdaq Listing Rule 5550(a)(2). This is a notice of deficiency and does not currently affect the listing or trading of the shares.
Guidance, Outlook, and Risks
- Compliance Timeline: The Company has 180 days, until February 2, 2026, to regain compliance by maintaining a closing bid price of at least $1.00 per share for 10 consecutive business days.
- Extension Eligibility: A second 180-day compliance period may be available if, by February 2, 2026, the Company maintains a market value of publicly held shares of at least $1 million and meets all other initial listing standards.
- Delisting Risk: Failure to regain compliance during the cure period(s) will result in a delisting notification. The Company retains the right to appeal such a determination to a Nasdaq Hearings Panel.
- Management Commentary: Management intends to monitor the bid price and consider plans to regain compliance but explicitly states there is no assurance that compliance will be achieved.
Investor Verification Checklist
- Verify the current closing bid price of LFWD shares to assess the gap from the $1.00 threshold.
- Review the Company's most recent 10-K or 10-Q for the market value of publicly held shares to determine eligibility for a potential second compliance period.
- Monitor subsequent filings for any announced capital actions (e.g., reverse stock splits) intended to address the bid price deficiency.
- Check the Nasdaq website for any updates on the Company's compliance status or hearing panel decisions.